Journal profile · CLINICAL NEUROLOGY
Zeitschrift fur Epileptologie
ISSN 1617-6782 · eISSN 2948-1058 · Springer Nature · 4 issues per year
Zeitschrift fur Epileptologie: impact factor 1.1 (journal website); hybrid open access; APC about USD 3,390; review about 7 days (submission to first decision, publisher); 77 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Zeitschrift fur Epileptologie is published by Springer Nature. By OpenAlex counts of its recent articles, its largest topics are Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies and Neuroscience and Neuropharmacology Research, together about 52.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Ziel der Clinical Epileptology ist die Darstellung und Diskussion aktuellen epileptologischen Wissens im deutschsprachigen Raum mit dem Schwerpunkt klinisch relevanter Themen. Epileptologische Grundlagenerkenntnisse sowie Forschungsergebnisse werden ebenfalls berücksichtigt.Die Clinical Epileptology richtet sich hauptsächlich an Ärztinnen und Ärzte der Fachbereiche Neurologie und Pädiatrie mit einem speziellen Interesse an epileptologischer Diagnostik und Therapie.Als besondere Rubriken bietet die Zeitschrift: Übersichtsarbeit - Review Originalartikel Study protocol Short communication Clinical Image Editorials Mitteilungen der Gesellschaften: - Mitteilungen der Deutschen Gesellschaft für Epileptologie- Mitteilungen der Österreichischen Gesellschaft für Epileptologie- Mitteilungen der Schweizerischen Epilepsie-Liga- Mitteilungen der Stiftung Michael- Mitteilungen der Arbeitsgemeinschaft für prächirurgische Epilepsiediagnostik und operative Epilepsietherapie
From the journal's Aims & Scope
Research area (LetPub): CLINICAL NEUROLOGY
Editor-in-chief Edda HaberlandtPublisher website
Editorial board by country: 1 in mainland China (about 1%); most named Germany 34, Switzerland 9, Austria 7, United States 3, United Kingdom 3 (67 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Epilepsy research and treatmentMedicine31.5%
- Pharmacological Effects and Toxicity StudiesMedicine13.6%
- Neuroscience and Neuropharmacology ResearchNeuroscience7.6%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology6.5%
- Pharmaceutical studies and practicesMedicine5.4%
- Diet and metabolism studiesMedicine4.5%
- Neurological disorders and treatmentsMedicine2.4%
- Psychosomatic Disorders and Their TreatmentsMedicine2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ESCIEmbasePublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.1Publisher website ·
- CiteScore 2026-06
- 1.1LetPub ·
- SJR 2026-06
- 0.14LetPub ·
- SNIP 2026-06
- 0.09LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 28OpenAlex ·
- 2-year mean citedness
- 0.74OpenAlex ·
- Share of gold OA articles
- 39.58%LetPub ·
Volume
- Downloads per year (publisher) 2025
- 195,400Publisher website ·
Articles by year OpenAlex count · 1,560 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 30 | 14 |
| 2025 | 77 | 47 | 24 |
| 2024 | 88 | 47 | 124 |
| 2023 | 92 | 55 | 201 |
| 2022 | 89 | 45 | 86 |
| 2021 | 61 | 33 | 116 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
Too few articlesOnly 9 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Figures by source
- Submission to first decision
- 7 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,390 / EUR 2,790 / GBP 2,390 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
LLMs do not satisfy authorship criteria Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Conflict of interest
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. This note should be added in a separate section before the reference list. If no conflict exists, authors should state: The authors declare that they have no conflict of interest. Back to top
Source ↗Publisher website ·- Data availability
Research data archiving encouraged Model summary
We encourage research data to be archived in data repositories wherever possible.
Source ↗Publisher website ·- Publication ethics Ethical standards
Competing interests disclosure required Model summary
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed conse…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Clinical Epileptology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 1617-6782
- Print ISSN
- 2948-104X
- Electronic ISSN
- 2948-1058
- Latest issue on the website
- Volume 39, Issue 3 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Zeitschrift fur Epileptologie
What is the impact factor of Zeitschrift fur Epileptologie?
The journal's website gives an impact factor of 1.1 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1.1, h-index 14.
How long does peer review take at Zeitschrift fur Epileptologie?
The publisher reports about 7 days (submission to first decision); first decisions include desk rejections. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Zeitschrift fur Epileptologie?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Zeitschrift fur Epileptologie based?
Of the 67 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are Germany (34), Switzerland (9) and Austria (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Zeitschrift fur Epileptologie?
According to LetPub and DOAJ records, Zeitschrift fur Epileptologie is indexed in Scopus. The journal's website also lists ESCI and Embase; that list has not been checked against each database.
Is Zeitschrift fur Epileptologie open access, and what is the APC?
Zeitschrift fur Epileptologie is a hybrid journal. For open-access publication: APC about USD 3,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .